Drs. Nancy Kuntz and Laurent Servais report on exciting developments related to Duchenne Muscular Dystrophy shared at a recent international neuromuscular conference. Data from clinical trials in gene therapy for Duchenne show promising results after 4 years post-dosing. Find out more about the longevity of gene therapy for these patients.
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.